Is Guangxi Huluwa Pharmaceutical a state-owned enterprise?

Guangxi Huluwa Pharmaceutical is a state-owned enterprise. Huluwa Pharmaceutical Group, established in 2008, is a pediatric pharmaceutical enterprise and a high-tech enterprise in China. It is also a domestic pharmaceutical company selected as the vice chairman of the Pediatric Branch of the Chinese Medicine Association. Huluwa Pharmaceutical Group has four standardized production bases that have passed the new GMP certification, namely: Haikou Medicine Valley Production Base, Haikou Bonded Production Base, Guangxi Nanning Production Base and Hebei Chengde Production Base. There are 3/kloc-0 professional production lines for chemicals and traditional Chinese medicine. The production site is managed in full accordance with 5S management mode, and the quality management system strictly implements GMP standards. In recent years, the company has invested hundreds of millions of yuan to build a production base of medicine valley. Six modern preparation buildings and two intensive office buildings have been built, and the production equipment and research and development instruments are at the leading level. The company launched an efficient OA office system and a convenient financial management system, which laid a solid foundation for the company's rapid development. In 20 15, Huluwa Pharmaceutical Group successfully acquired Nanning Weiwei Pharmaceutical Co., Ltd., including all 65 product approvals, sales network, production equipment, original employees and its subordinate Guangxi Pingle Chinese Medicine Extraction and Production Base, and completed the seamless connection between production and sales in 15438+0. At present, Huluwa Pharmaceutical Group has a series of products with three brands as the main body, namely, Huluwa, Huluwa Dad and Huluwa Mom, with nearly 300 product specifications. The products have covered pediatrics, gynecology, ophthalmology, orthopedics, respiratory, digestive, hepatobiliary, urology, neurology, infectious diseases and other treatment fields.